Hims & Hers Health, Inc. (HIMS) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2025
Loading P/E history...
HIMS Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, Hims & Hers Health, Inc. (HIMS) trades at a price-to-earnings ratio of 52.7x, with a stock price of $26.88 and trailing twelve-month earnings per share of $0.52.
The current P/E is 41% below its 5-year average of 89.2x. Over the past five years, HIMS's P/E has ranged from a low of 42.6x to a high of 263.9x, placing the current valuation at the 43th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, HIMS trades at a 138% premium to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, HIMS commands a significant premium over the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HIMS DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HIMS P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $5B | 23.1 | 0.29Best | +54% | |
| $121M | 24.0 | - | +125%Best | |
| $152B | 155.7 | - | -11% | |
| $203B | 12.7Lowest | 0.61 | +2% | |
| $933B | 43.0 | 1.49 | +96% | |
| $869M | 129.8 | - | - | |
| $881M | 30.1 | - | +104% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
HIMS Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $32.47 | $0.51 | 63.2x | -29% |
| FY2025 Q3 | $56.72 | $0.54 | 104.4x | +17% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $49.85 | $0.80 | 62.3x | -30% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $29.55 | $0.69 | 43.0x | -52% |
| FY2024 Q4 | $24.18 | $0.54 | 45.1x | -49% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $18.42 | $0.43 | 42.6x | -52% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $20.19 | $0.08 | 263.9x | +196% |
Average P/E for displayed period: 89.2x
See HIMS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HIMS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HIMS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHIMS — Frequently Asked Questions
Quick answers to the most common questions about buying HIMS stock.
Is HIMS stock overvalued or undervalued?
HIMS trades at 52.7x P/E, below its 5-year average of 89.2x. At the 43th percentile of historical range, the stock is priced at a discount to its own history.
How does HIMS's valuation compare to peers?
Hims & Hers Health, Inc. P/E of 52.7x compares to sector median of 22.1x. The premium reflects expected growth above peers.
What is HIMS's PEG ratio?
HIMS PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2024-2025.